DBV Technologies
Latest round
- Series C
Last raised
- Dec 2010
Total raised
- $48M
Investors
- 9
About DBV Technologies
DBV Technologies SA specializes in immunotherapy solutions for food allergies. Founded in 2002, the company is headquartered in Montrouge, France. Pierre-Yves Vannerom was instrumental in establishing the company.DBV Technologies focuses on developing innovative epicutaneous immunotherapy solutions, primarily with its flagship product, the VIASKIN® patch. This technology aims to treat food allergies, particularly peanut and cow's milk allergies, by delivering small amounts of allergen through the skin, helping re-educate the immune system. The patch is designed for patients, including children and adolescents, facing severe allergic reactions, aiming to improve their quality of life and reduce the risk of anaphylaxis.DBV Technologies operates a B2B model, collaborating with healthcare organizations and research institutions to advance clinical trials and product development.60, indicating the ongoing investment in research and regulatory processes for its investigational therapies.DBV Technologies plans to launch new products using its research into the VIASKIN® patch and other therapies within the next few years. The company is targeting expansion into new geographic regions, particularly in Asia and Latin America, by 2025.
Who invested in DBV Technologies
9 investors across 4 rounds
See all investors in DBV Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DBV Technologies
Who invested in DBV Technologies?
DBV Technologies has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DBV Technologies raised?
DBV Technologies has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did DBV Technologies last raise money?
DBV Technologies's most recent round on record is a Series C, in Dec 2010.
What does DBV Technologies do?
DBV Technologies SA specializes in immunotherapy solutions for food allergies.
Where is DBV Technologies headquartered?
DBV Technologies is headquartered in Montrouge, France.
Which VCs invest in companies like DBV Technologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at DBV Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like DBV Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.